Current filters:  
USA
IP
Cayman Islands
HSM IP
Trademarks Comparative Guide for the jurisdiction of Cayman Islands, check out our comparative guides section to compare across multiple countries
United States
Axinn Veltrop & Harkrider
A claimant's recovery of attorneys' fees in a trade secret action ordinarily reflects an overwhelming success at trial.
Pryor Cashman LLP
Pryor Cashman Partner Ilene Farkas, co-chair of the Litigation and Music Groups and of the Copyright, M+E Litigation, and Music Litigation Practices, has been named to the "Copyright Lawyer of the Year"...
Oblon, McClelland, Maier & Neustadt, L.L.P
Effective March 29, 2024, the U.S. Patent and Trademark Office (USPTO) issued a final rule to revise 37 C.F.R. §§ 90.2, 90.3, and 2.145 by updating how the following documents are to be filed with the USPTO Director...
Harness IP
We've all seen it. Patent attorneys love making up words. For example, instead of claiming a pipe, a hose, or a tube, we draft patent claims reciting "a fluid delivery system" or "a fluid conduit."
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
If a US patent maintenance fee has not been paid in a timely manner and the owner of the patent wants to get the patent rights reinstated...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The First-Time Filer Expedited Examination Pilot Program, implemented by the U.S. Patent and Trademark Office (USPTO) and its Council for Inclusive Innovation (CI2)...
Jones Day
Director Vidal recently vacated the Patent Trial and Appeal Board's (PTAB) decision to deny institution of three petitions for inter partes review (IPR), citing insufficient explanation...
Sheppard Mullin Richter & Hampton
This case addresses whether the district court's grant of summary judgment was proper based on the district court's finding that the asserted claims of U.S. Patent No. 8,197,807 ("the '807 patent") were invalid under 35 U.S.C. § 101 for being directed to a natural phenomenon.
Goodwin Procter LLP
On April 1, 2024, the Federal Circuit released its opinion in Janssen Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al., affirming the district court's finding that certain claims were not indefinite and remanding to the district court to reevaluate its obviousness decision.
Axinn Veltrop & Harkrider
Much like secondary considerations, non-infringing alternatives fit imperfectly within many scheduling orders. The patentee has the burden of proof on damages...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Affirming the district court's award of summary judgment for the band Nickelback, the Fifth Circuit found a copyright plaintiff's circumstantial evidence insufficient...
NovoTech Patent Firm
Under 35 U.S.C. § 287, often referred to as the patent marking statute, there exists a critical framework for patent owners in the United States regarding the marking of patented products.
Goodwin Procter LLP
The availability of post-grant proceedings at the Patent Trial and Appeal Board (PTAB) has changed the face of patent litigation. This periodic digest is designed to keep you up-to-date by highlighting...
Foley & Lardner
The new fee proposals from the U.S. Patent & Trademark Office have one thing in common: encouraging applicants to have quick examinations and avoiding strategies...
Foley & Lardner
The USPTO has taken another step toward implementing fee adjustments in January 2025, by publishing a Notice of Proposed Rulemaking (RPRM) on April 3, 2024.
Akin Gump Strauss Hauer & Feld LLP
The Patent Trial and Appeal Board recently found claims directed to a web-based point of sale system and method unpatentable as obvious after conducting a thorough examination of whether a reference with one common inventor constituted prior art.
Greenberg Traurig, LLP
Emerging technologies continue to reshape industries and societies, introducing unprecedented advancements that are changing the way we work and live. At the same time...
Greenberg Traurig, LLP
Patents buttress and backstop growth for medical technology (medtech) companies, period. This is especially so for early-stage ventures staking their claim in the medtech ecosystem.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
The U.S. Patent and Trademark Office has kicked off 2024 with several policymaking initiatives.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media